WELCH_CHEMISTS_LIMITED - Accounts

Company Registration No. SC165799 (Scotland)
WELCH CHEMISTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2020
PAGES FOR FILING WITH REGISTRAR
WELCH CHEMISTS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
WELCH CHEMISTS LIMITED
BALANCE SHEET
AS AT 30 NOVEMBER 2020
30 November 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
3
76,913
83,515
Current assets
Stocks
87,317
111,599
Debtors
4
1,160,519
523,474
Cash at bank and in hand
606,933
750,706
1,854,769
1,385,779
Creditors: amounts falling due within one year
5
(631,543)
(654,562)
Net current assets
1,223,226
731,217
Total assets less current liabilities
1,300,139
814,732
Provisions for liabilities
(6,217)
(6,650)
Net assets
1,293,922
808,082
Capital and reserves
Called up share capital
6
76,600
76,600
Revaluation reserve
7
42,980
42,980
Capital redemption reserve
78,900
78,900
Profit and loss reserves
1,095,442
609,602
Total equity
1,293,922
808,082

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial Year ended 30 November 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the Year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

WELCH CHEMISTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2020
30 November 2020
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 August 2021 and are signed on its behalf by:
Mr Arif Hanif
Director
Company Registration No. SC165799
WELCH CHEMISTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2020
- 3 -
1
Accounting policies
Company information

Welch Chemists Limited is a private company limited by shares incorporated in Scotland. The registered office is 1st Floor, 133 Finnieston Street, Glasgow, G3 8HB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover comprises revenue recognised by the company in respect of pharmaceutical services provided during the year, exclusive of Value Added Tax and trade discounts.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Heritable Property
2% straight line
Fixtures and fittings
25% straight line
Equipment
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are valued at the lower of cost and net realisable value.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

WELCH CHEMISTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2020
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

WELCH CHEMISTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2020
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the Year was 17 (2019 - 16).

3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 December 2019
60,000
81,247
141,247
Additions
-
0
169
169
Disposals
-
0
(54,219)
(54,219)
At 30 November 2020
60,000
27,197
87,197
Depreciation and impairment
At 1 December 2019
-
0
57,732
57,732
Depreciation charged in the Year
-
0
6,771
6,771
Eliminated in respect of disposals
-
0
(54,219)
(54,219)
At 30 November 2020
-
0
10,284
10,284
Carrying amount
At 30 November 2020
60,000
16,913
76,913
At 30 November 2019
60,000
23,515
83,515
4
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
395,190
460,652
Other debtors
765,329
62,822
1,160,519
523,474
WELCH CHEMISTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2020
- 6 -
5
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
273,460
278,153
Corporation tax
115,578
150,818
Other taxation and social security
7,109
6,322
Other creditors
235,396
219,269
631,543
654,562
6
Called up share capital
2020
2019
£
£
Ordinary share capital
Issued and fully paid
34,470 A Ordinary of £1 each
34,470
34,470
34,470 B Ordinary of £1 each
34,470
34,470
3,830 C Ordinary of £1 each
3,830
3,830
3,830 D Ordinary of £1 each
3,830
3,830
76,600
76,600
7
Revaluation reserve
2020
2019
£
£
At the beginning and end of the Year
42,980
42,980
2020-11-302019-12-01false30 August 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityMr A HanifMr J ConnollySC1657992019-12-012020-11-30SC1657992020-11-30SC1657992019-11-30SC165799core:LandBuildings2020-11-30SC165799core:OtherPropertyPlantEquipment2020-11-30SC165799core:LandBuildings2019-11-30SC165799core:OtherPropertyPlantEquipment2019-11-30SC165799core:CurrentFinancialInstrumentscore:WithinOneYear2020-11-30SC165799core:CurrentFinancialInstrumentscore:WithinOneYear2019-11-30SC165799core:CurrentFinancialInstruments2020-11-30SC165799core:CurrentFinancialInstruments2019-11-30SC165799core:ShareCapital2020-11-30SC165799core:ShareCapital2019-11-30SC165799core:RevaluationReserve2020-11-30SC165799core:RevaluationReserve2019-11-30SC165799core:CapitalRedemptionReserve2020-11-30SC165799core:CapitalRedemptionReserve2019-11-30SC165799core:RetainedEarningsAccumulatedLosses2020-11-30SC165799core:RetainedEarningsAccumulatedLosses2019-11-30SC165799core:ShareCapitalOrdinaryShares2020-11-30SC165799core:ShareCapitalOrdinaryShares2019-11-30SC165799bus:Director12019-12-012020-11-30SC165799core:LandBuildingscore:OwnedOrFreeholdAssets2019-12-012020-11-30SC165799core:FurnitureFittings2019-12-012020-11-30SC165799core:ComputerEquipment2019-12-012020-11-30SC165799core:MotorVehicles2019-12-012020-11-30SC1657992018-06-012019-11-30SC165799core:LandBuildings2019-11-30SC165799core:OtherPropertyPlantEquipment2019-11-30SC1657992019-11-30SC165799core:LandBuildings2019-12-012020-11-30SC165799core:OtherPropertyPlantEquipment2019-12-012020-11-30SC165799core:WithinOneYear2020-11-30SC165799core:WithinOneYear2019-11-30SC165799bus:PrivateLimitedCompanyLtd2019-12-012020-11-30SC165799bus:SmallCompaniesRegimeForAccounts2019-12-012020-11-30SC165799bus:FRS1022019-12-012020-11-30SC165799bus:AuditExemptWithAccountantsReport2019-12-012020-11-30SC165799bus:Director22019-12-012020-11-30SC165799bus:FullAccounts2019-12-012020-11-30xbrli:purexbrli:sharesiso4217:GBP